Free Trial
TSE:RVX

Resverlogix (RVX) Stock Price, News & Analysis

Resverlogix logo
C$0.10 +0.01 (+11.11%)
As of 08/1/2025 03:54 PM Eastern

About Resverlogix Stock (TSE:RVX)

Key Stats

Today's Range
C$0.10
C$0.10
50-Day Range
C$0.04
C$0.23
52-Week Range
C$0.04
C$0.30
Volume
284,726 shs
Average Volume
112,881 shs
Market Capitalization
C$19.79 million
P/E Ratio
N/A
Dividend Yield
7.02%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resverlogix and its competitors with MarketBeat's FREE daily newsletter.

RVX Stock News Headlines

This Crypto Is Set to Explode in January
Free summit reveals where Bitcoin goes after $120k Don't miss this rare opportunity to learn directly from the experts who are driving this market…
Resverlogix Corp. (RVXCF)
See More Headlines

RVX Stock Analysis - Frequently Asked Questions

Resverlogix's stock was trading at C$0.06 at the beginning of the year. Since then, RVX stock has increased by 81.8% and is now trading at C$0.10.

Resverlogix Corp. (TSE:RVX) posted its quarterly earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.03) earnings per share for the quarter.

Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Resverlogix investors own include ProMetic Life Sciences (PLI), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), Oncolytics Biotech (ONC), Radient Technologies (RTI), VentriPoint Diagnostics (VPT) and Burcon NutraScience (BU).

Company Calendar

Last Earnings
11/12/2024
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:RVX
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.81 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
6.06%
Return on Assets
-34.90%

Debt

Debt-to-Equity Ratio
-10.95
Current Ratio
0.13
Quick Ratio
0.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
132.50
Book Value
C($0.23) per share
Price / Book
-0.43

Miscellaneous

Outstanding Shares
197,937,403
Free Float
N/A
Market Cap
C$19.79 million
Optionable
Not Optionable
Beta
0.71
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (TSE:RVX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners